US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 18, 2019 (7 years ago)

Liothyronine

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

What was recalled

Liothyronine (T3) 92.5 MCG

Recalling firm
MPRX, Inc. dba Medical Park Pharmacy
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0808-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Liothyronine recalls

See all
Class II · Moderate risk Terminated

Liothyronine Sodium Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries INC NDC 62756-589-88 D-0150-2024
Class II · Moderate risk Terminated

Liothyronine Sodium Tablets

Reason Failed Impurities/Degradation Specifications.

Sun Pharmaceutical Industries INC NDC 62756-590-88 D-0084-2024
Class II · Moderate risk Terminated

Liothyronine Sodium Tablets

Reason Failed Impurities/Degradation Specifications.

Sun Pharmaceutical Industries INC NDC 62756-589-88 D-0083-2024
Class II · Moderate risk Terminated

Nature-Throid 1 GR

Reason CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.

PD-Rx Pharmaceuticals, Inc. NDC 43063-819-01 D-0005-2021
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020